Aspirin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

60 Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 1 EU WC, 4 KDMF, 31 NDC API, 29 Listed Suppliers

DEVELOPMENTS

34 Drug(s) in Development

34 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

432 Dossiers, 117 FDA Orange Book, 93 Europe, 91 Canada, 12 Australia, 25 South Africa, 94 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

Suppliers, 47 Roquette, 40 BASF, 40 Kerry, 31 SPI Pharma, 24 DKSH, 24 Microlex e.U, 19 Seppic, 17 Ideal Cures Pvt Ltd, 16 Nanjing Well Pharmaceutical, 16 Gangwal Chemicals, 15 Corel Pharma Chem, 15 Gangwal Healthcare, 15 Actylis, 13 Rochem International Inc, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 Pluviaendo, 12 Sigachi Industries, 8 Boai NKY Pharmaceuticals Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 5 Kima Chemical, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 5 Vasa Pharmachem, 4 Novo Excipients, 4 The Dow Chemical Company, 4 ACG Worldwide, 3 Clariant, 3 Ulanqab Kema New Material, 3 Evonik, 3 Finar, 3 Doshion Polyscience, 3 Jai Radhe Sales, 3 Alcedo Pharmachem, 3 Pharm-RX Chemical, 2 Valens Pharmachem, 2 Qualicaps, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Aeon Procare, 2 Minakem, 2 Pfanstiehl, 2 Seqens, 2 Nomisma Healthcare, 2 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 Vertellus, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 1 Chynops Pharma

EXCIPIENTS BY APPLICATIONS

127 Fillers, Diluents & Binders, 89 Coating Systems & Additives, 52 Thickeners and Stabilizers, 51 Direct Compression, 50 Controlled & Modified Release, 50 Solubilizers, 48 Disintegrants & Superdisintegrants, 46 Taste Masking, 38 Parenteral, 37 Granulation, 34 Topical, 32 Film Formers & Plasticizers, 31 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 14 API Stability Enhancers, 13 Emulsifying Agents, 11 Rheology Modifiers, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 53 Finished Drug Prices

MARKET PLACE

52 APIs, 43 DOSSIERS // FDF

PATENTS

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 BioAnalytical Methods, 2 EDQM, 1 USP, 1 JP, 8 Others

DIGITAL CONTENT

10 Data Compilation & Company Tracker #PharmaFlow, 182 News

Drug Approvals by the Medicines Control Council in South Africa containing Aspirin. Original Data : South African Medicines Price Registry

Aspirin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

60 Suppliers

26 USDMF

9 CEP/COS

6 JDMF

1 EU WC

4 KDMF

31 NDC API

29 Listed Suppliers

DEVELOPMENTS

34 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

432 Dossiers

117 FDA Orange Book

93 Europe

91 Canada

12 Australia

25 South Africa

94 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET;ORAL - 250MG;250MG;65MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

Suppliers

47 Roquette

40 BASF

40 Kerry

31 SPI Pharma

24 DKSH

24 Microlex e.U

19 Seppic

17 Ideal Cures Pvt Ltd

16 Nanjing Well Pharmaceutical

16 Gangwal Chemicals

15 Corel Pharma Chem

15 Gangwal Healthcare

15 Actylis

13 Rochem International Inc

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

12 Pluviaendo

12 Sigachi Industries

8 Boai NKY Pharmaceuticals Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 DFE Pharma

6 Lonza Capsugel

5 Kima Chemical

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Pharmatrans-Sanaq

5 Vasa Pharmachem

4 Novo Excipients

4 The Dow Chemical Company

4 ACG Worldwide

3 Clariant

3 Ulanqab Kema New Material

3 Evonik

3 Finar

3 Doshion Polyscience

3 Jai Radhe Sales

3 Alcedo Pharmachem

3 Pharm-RX Chemical

2 Valens Pharmachem

2 Qualicaps

2 Shijiazhuang Huaxu Pharmaceutical

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons